GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the second quarter ended 30th June 2010. Net Sales of the pharmaceuticals business grew by 12% during the quarter. Overall, Net Sales have grown by 9% during the quarter ended 30th June 2010 and by 14% during the half year ended 30th June 2010.
The ongoing pharmaceuticals business continued to build with improvement in margins. Operating Profit before investment income grew by 14% during the quarter ended 30th June 2010 and by 18% during the half year ended 30th June 2010.
Commenting on the performance during the quarter, Dr. Hasit B. Joshipura, Managing Director, said, ?The growth momentum continued in the pharmaceutical business with competitive growth in the mass markets, mass specialities and specialities businesses. During the quarter, sales of vaccines were significantly impacted on account of constraints on supply. The availability of vaccines, however, has been improving towards the end of the quarter.?